Adarsh Medico Profile
Key Indicators
- Authorised Capital ₹ 2.60 M
as on 17-07-2024
- Paid Up Capital ₹ 2.55 M
as on 17-07-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 17-07-2024
- Satisfied Charges ₹ 2.50 M
as on 17-07-2024
- Revenue 20.25%
(FY 2023)
- Profit 40.86%
(FY 2023)
- Ebitda 55.35%
(FY 2023)
- Net Worth 34.38%
(FY 2023)
- Total Assets 36.74%
(FY 2023)
About Adarsh Medico
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 M and a paid-up capital of Rs 2.55 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sushil Batra, Arun Batra, and Neelam Batra serve as directors at the Company.
- CIN/LLPIN
U24231UR1988PTC010001
- Company No.
010001
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Adarsh Medico?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Batra  | Managing Director | 05-Sep-1988 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun Batra | Whole-Time Director | 26-Oct-2012 | Current |
| Neelam Batra | Whole-Time Director | 26-Oct-2012 | Current |
Financial Performance of Adarsh Medico.
Adarsh Medico Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.25% increase. The company also saw a substantial improvement in profitability, with a 40.86% increase in profit. The company's net worth Soared by an impressive increase of 34.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adarsh Medico?
In 2023, Adarsh Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 20 Feb 2002 | ₹5.00 M | Open |
Others Creation Date: 08 Mar 2018 | ₹2.30 M | Satisfied |
State Bank Of India Creation Date: 06 Feb 1990 | ₹0.20 M | Satisfied |
How Many Employees Work at Adarsh Medico?
Unlock and access historical data on people associated with Adarsh Medico, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adarsh Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adarsh Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
